News and Events

ChemBridge to Attend and Exhibit at SelectBio Advances in Drug Discovery, Cambridge, United Kingdom, March 6-7, 2017

San Diego, CA, USA, February 21, 2017

SelectBio Advances in Drug Discovery will take place March 6-7, 2017, in Cambridge, United Kingdom. With over 300 attendees expected, this multi-track event will build on the success of the SelectBio Cambridge Workshop Series and will feature four tracks:

  • Epigenetics in Drug Discovery
  • Antibodies in Drug Discovery
  • Academic Drug Discovery
  • Stem Cells in Drug Discovery

ChemBridge will be present to discuss our products and services related to small molecule drug discovery and chemical biology research including:

  • Stock of more than 14,000 chemical building blocks / reagents for medicinal chemists
  • Stock of more than 1.1 million small molecule screening compounds including sp3-enriched screening compounds with more 3-dimensional structure.
  • Diversity screening libraries including the DIVERSet and PremiumSet Libraries
  • Targeted screening libraries and biased screening libraries for kinase, ion channel, GPCR, nuclear receptor and CNS research
  • Our new Macrocycle Library compounds

Please visit ChemBridge in the exhibition area or contact Dr. Reg Richardson, European Business Manager, at reg@chembridge.com to arrange a meeting at the conference.

back to top